S&P 500 7,570.31 -0.52% NASDAQ 26,882.83 -0.78% DOW 50,883.88 -0.83% R2K 2,897.39 -1.18% VIX 16.08 +1.97%
Next Bullish Trade
IDXX IDEXX Laboratories, Inc. NMS
$557.41 +6.59 (+1.20%)
Neutral · +0.04σ
+ Compare Set alert Open in Sniper

Price chart

Overlay: Click earnings ▲ markers for day-move details

Loading 1Y daily…

Financial overlay · last 12 quarters

QuarterRevenue Net incomeOp income FCFNet margin Op margin
2026-03-31 $1.1B $0.3B $0.4B $0.2B 24.4% 31.8%
2025-12-31 $1.1B $0.2B $0.3B $0.3B 22.8% 28.9%
2025-09-30 $1.1B $0.3B $0.4B $0.4B 24.8% 32.1%
2025-06-30 $1.1B $0.3B $0.4B $0.2B 26.5% 33.6%
2025-03-31 $1.0B $0.2B $0.3B $0.2B 24.3% 31.7%

Earnings replay · last 20 reports

DateEPS actual EPS estSurprise
2026-05-05 3.47 3.41 +1.7%
2026-02-02 3.08 2.94 +4.8%
2025-11-03 3.40 3.15 +8.1%
2025-08-04 3.63 3.30 +10.0%
2025-05-01 2.96 2.85 +3.9%
2025-02-03 2.62 2.40 +9.2%
2024-10-31 2.80 2.69 +4.3%
2024-08-06 3.02 2.87 +5.2%
2024-05-01 2.81 2.68 +4.8%
2024-02-05 2.32 2.12 +9.4%
2023-11-01 2.53 2.37 +6.7%
2023-08-01 2.67 2.47 +8.2%
2023-05-02 2.55 2.43 +4.9%
2023-02-06 2.05 1.92 +6.5%
2022-11-01 2.15 2.04 +5.5%
2022-08-02 1.56 1.63 -4.1%
2022-05-04 2.27 2.25 +1.0%
2022-02-02 1.89 1.72 +9.9%
2021-11-02 2.03 1.91 +6.1%
2021-07-30 2.34 2.04 +14.6%

Earnings markers are overlaid on the price chart above. Transcript summaries require PERPLEXITY_API_KEY (deferred to a follow-up).

Peer comparison · Healthcare

Ticker ⇅ Mkt cap ⇅ P/E ⇅ Fwd P/E ⇅ P/S ⇅ EV/EBITDA ⇅ P/B ⇅ Gross M ⇅ Rev gr ⇅ EPS gr ⇅ FCF yld ⇅
IDXX ★ $44B 41.0 33.7 9.9 28.7 28.4 62.1% 14.3% 17.2% 1.79%
LLY $972B 38.6 24.5 13.5 27.3 31.2 82.8% 55.5% 169.9% 0.94%
UNH $346B 28.8 18.3 0.8 18.5 3.5 18.8% 2.0% 0.7% 5.11%
JNJ $539B 25.9 17.6 5.6 16.6 6.6 68.0% 9.9% -52.9% 2.32%
MRK $285B 32.5 12.0 4.3 11.2 6.2 76.7% 4.9% — 4.94%
ABBV $386B 106.7 13.5 6.1 14.8 -58.0 72.0% 12.4% -46.2% 5.39%
PFE $145B 19.4 9.0 2.3 7.8 1.6 74.8% 5.4% -10.1% 8.54%
TMO $176B 26.1 17.4 3.9 19.4 3.3 40.9% 6.2% 11.3% 3.13%

Auto-seeded from sector. Click any ticker to switch.

Ownership

Top institutional holders

Top-10 concentration: 39.81%

HolderShares% out
Blackrock Inc. 8,365,553 10.61%
Vanguard Capital Management LLC 5,182,507 6.57%
Vanguard Portfolio Management LLC 3,910,863 4.96%
State Street Corporation 3,674,185 4.66%
Geode Capital Management, LLC 2,660,999 3.37%
Invesco Ltd. 1,678,556 2.13%
BAMCO Inc. 1,633,367 2.07%
Bank Of New York Mellon Corporation 1,504,532 1.91%
Fundsmith LLP 1,465,786 1.86%
Morgan Stanley 1,315,954 1.67%

Insider activity · 90d

No insider trades for IDXX in last 90d.

Analyst estimates

yfinance
Low
$470.0
Mean
$709.1429
High
$805.0
Analysts
14

Consensus: buy (mean 2.13333). Distribution requires FINNHUB_API_KEY.

SEC filings

FormFiled DescriptionAction
4 2026-06-02 FORM 4 view ·
8-K 2026-05-15 8-K view ·
4 2026-05-14 FORM 4 view ·
4 2026-05-14 FORM 4 view ·
4 2026-05-14 FORM 4 view ·
4 2026-05-14 FORM 4 view ·
4 2026-05-14 FORM 4 view ·
4 2026-05-14 FORM 4 view ·
4 2026-05-14 FORM 4 view ·
4 2026-05-14 FORM 4 view ·
4 2026-05-14 FORM 4 view ·
4 2026-05-11 FORM 4 view ·
4 2026-05-11 FORM 4 view ·
4 2026-05-11 FORM 4 view ·
4 2026-05-11 FORM 4 view ·
4 2026-05-11 FORM 4 view ·
4 2026-05-11 FORM 4 view ·
10-Q 2026-05-05 10-Q view ·
8-K 2026-05-05 FORM 8-K view ·
4 2026-05-04 FORM 4 view ·
DEF 14A 2026-03-27 DEF 14A view ·
8-K 2026-03-26 FORM 8-K view ·
4 2026-03-05 FORM 4 view ·
4 2026-03-05 FORM 4 view ·
4 2026-03-02 FORM 4 view ·
4 2026-02-27 FORM 4 view ·
10-K 2026-02-20 10-K view ·
4 2026-02-19 FORM 4 view ·
4 2026-02-19 FORM 4 view ·
4 2026-02-17 FORM 4 view ·
4 2026-02-17 FORM 4 view ·
4 2026-02-17 FORM 4 view ·
4 2026-02-17 FORM 4 view ·
4 2026-02-17 FORM 4 view ·
4 2026-02-17 FORM 4 view ·
4 2026-02-17 FORM 4 view ·
4 2026-02-17 FORM 4 view ·
4 2026-02-17 FORM 4 view ·
4 2026-02-17 FORM 4 view ·
8-K 2026-02-13 8-K view ·
4 2026-02-11 FORM 4 view ·
4 2026-02-03 FORM 4 view ·
8-K 2026-02-02 FORM 8-K view ·
8-K 2026-01-13 FORM 8-K view ·
4 2025-12-03 FORM 4 view ·
8-K 2025-11-13 FORM 8-K view ·
4 2025-11-10 FORM 4 view ·
4 2025-11-03 FORM 4 view ·
10-Q 2025-11-03 10-Q view ·
8-K 2025-11-03 FORM 8-K view ·
8-K 2025-10-07 FORM 8-K view ·
4 2025-09-04 FORM 4 view ·
4 2025-09-03 FORM 4 view ·
4 2025-09-03 FORM 4 view ·
4 2025-08-26 FORM 4 view ·
4 2025-08-14 FORM 4 view ·
4 2025-08-13 FORM 4 view ·
4 2025-08-12 FORM 4 view ·
4 2025-08-12 FORM 4 view ·
4 2025-08-11 FORM 4 view ·

About

IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. It operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. The company offers point-of-care diagnostic solutions, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology/morphology, and coagulation analyzers; and SNAP rapid assays test kits. It also provides commercial reference laboratory diagnostic and consulting services to veterinarians; veterinary consultation, telemedicine, and advisory services, including radiology, dental radiography, cardiology, internal medicine, and ultrasound consulting; Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, Quanti-Tray products, and Tecta system instruments; UV Viewer Plus, a UV light cabinet which aids in the visual interpretation of fluorescent-based water tests; and veterinary software and services for independent veterinary clin…